InfuSystems Holdings Inc (INFU)
7.14
+0.07
(+0.99%)
USD |
NYAM |
May 31, 16:00
7.13
-0.01
(-0.14%)
Pre-Market: 20:00
InfuSystems Holdings SG&A Expense (Annual): 58.03M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 58.03M |
| December 31, 2022 | 56.41M |
| December 31, 2021 | 51.45M |
| December 31, 2020 | 44.86M |
| December 31, 2019 | 38.92M |
| December 31, 2018 | 33.74M |
| December 31, 2017 | 33.82M |
| December 31, 2016 | 34.29M |
| December 31, 2015 | 34.20M |
| December 31, 2014 | 29.73M |
| Date | Value |
|---|---|
| December 31, 2013 | 28.63M |
| December 31, 2012 | 32.93M |
| December 31, 2011 | 27.36M |
| December 31, 2010 | 27.71M |
| December 31, 2009 | 17.48M |
| December 31, 2008 | 16.42M |
| December 31, 2007 | 6.124M |
| December 31, 2006 | 20.82M |
| December 31, 2005 | 0.0245M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
38.92M
Minimum
2019
58.03M
Maximum
2023
49.93M
Average
51.45M
Median
2021
SG&A Expense (Annual) Benchmarks
| Haemonetics Corp | 431.78M |
| Perspective Therapeutics Inc | 21.06M |
| Xtant Medical Holdings Inc | 64.29M |
| Asensus Surgical Inc | 36.08M |
| Catheter Precision Inc | 17.12M |